Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Patient Perception of Visual Distortions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02203747
Recruitment Status : Completed
First Posted : July 30, 2014
Results First Posted : December 22, 2015
Last Update Posted : December 22, 2015
Sponsor:
Information provided by (Responsible Party):
Abbott Medical Optics

Brief Summary:
The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.

Condition or disease Intervention/treatment
Cataract Astigmatism Other: Administration of patient self-assessment

Layout table for study information
Study Type : Observational
Actual Enrollment : 79 participants
Observational Model: Case Control
Time Perspective: Prospective
Study Start Date : August 2014
Actual Primary Completion Date : October 2014
Actual Study Completion Date : January 2015

Group/Cohort Intervention/treatment
Pseudophakic implanted with toric IOL
Subjects bilaterally implanted with toric IOL
Other: Administration of patient self-assessment
Pseudophakic implanted with non-toric IOL
Subjects bilaterally implanted with non-toric IOL
Other: Administration of patient self-assessment



Primary Outcome Measures :
  1. Visual Distortion Symptoms [ Time Frame: Baseline ]
    Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.

  2. Visual Distortion Symptoms [ Time Frame: 1 week ]
    Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   22 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Bilaterally-implanted pseudophakic subjects over 22 years of age with astigmatism who meet the inclusion criteria.
Criteria

Inclusion Criteria:

  • Corneal astigmatism of at least 0.75 diopters
  • Bilaterally-implanted with monofocal toric intraocular lenses in both eyes or with monofocal non-toric intraocular lenses in both eyes
  • At least one month postoperative from second-eye surgery
  • Ability to understand, read and write English to give consent and complete study questionnaire
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
  • Sign informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
  • Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

  • Any ocular pathology of clinical significance, as determined by the investigator, other than regular corneal astigmatism, that may affect visual outcomes or influence subjective ocular visual symptoms
  • Patient is pregnant or is lactating
  • Participation in any other clinical trial during the last 30 days prior to study enrollment or concurrent participation in any other ongoing clinical trial
  • Other protocol-defined exclusion criteria may apply

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02203747


Locations
Layout table for location information
United States, California
Contact AMO for Trial Locations
Santa Ana, California, United States, 92705
Sponsors and Collaborators
Abbott Medical Optics

Layout table for additonal information
Responsible Party: Abbott Medical Optics
ClinicalTrials.gov Identifier: NCT02203747     History of Changes
Other Study ID Numbers: TIOL-201-VPAS
First Posted: July 30, 2014    Key Record Dates
Results First Posted: December 22, 2015
Last Update Posted: December 22, 2015
Last Verified: September 2015

Additional relevant MeSH terms:
Layout table for MeSH terms
Cataract
Astigmatism
Lens Diseases
Eye Diseases
Refractive Errors